Covid vs flu
Pro Research Analysisby 
Searched over 200M research papers
COVID-19 vs. Influenza: A Comparative Analysis
Clinical Symptoms and Presentation
Common Symptoms in COVID-19 and Influenza
COVID-19 and influenza share several clinical features, making it challenging to distinguish between the two based on symptoms alone. Both diseases commonly present with fever and cough. However, influenza patients are more likely to experience runny nose, sore throat, and rhinorrhea compared to COVID-19 patients 12. COVID-19 patients, on the other hand, are more likely to report neurologic symptoms and diarrhea .
Unique Clinical Manifestations
COVID-19 patients often exhibit ground-glass opacities and interlobular septal thickening on radiographic imaging, whereas influenza patients typically show consolidations and linear opacities . Additionally, COVID-19 patients are more frequently transferred to intensive care units and have a higher rate of mortality compared to those with influenza 24.
Laboratory Findings
Differences in Laboratory Results
Influenza patients tend to have higher white cell counts and procalcitonin levels, while COVID-19 patients are more likely to exhibit thrombopenia and elevated transaminases . Elevated C-reactive protein and lymphocytopenia are common laboratory findings in both diseases, but these markers are particularly pronounced in COVID-19 .
Radiographic Findings
Chest Radiology
Abnormal chest radiology is more prevalent in COVID-19 patients (84%) compared to those with influenza type A (57%) and type B (33%) . Ground-glass opacities are a hallmark of COVID-19, whereas influenza is more likely to show consolidations .
Hospitalization and Mortality
Duration and Outcomes
COVID-19 patients generally have a longer hospital stay (14 days) compared to those with influenza type A (6.5 days) and type B (6.7 days) . The case fatality rate for hospitalized COVID-19 patients is also higher (6.5%) compared to influenza type A (6%) and type B (3%) .
Intensive Care and Complications
COVID-19 patients are more likely to require intensive care and experience severe complications such as acute respiratory distress syndrome (ARDS), pulmonary embolism, and deep vein thrombosis 47. The risk of ARDS is nearly 19 times higher in COVID-19 patients compared to those with influenza .
Coinfections and Comorbidities
Coinfection Rates
The prevalence of influenza co-infection in COVID-19 patients is relatively low, estimated at 0.8% . However, the presence of both viruses can complicate diagnosis and treatment, particularly in high-risk individuals and the elderly .
Comorbidities
COVID-19 patients are more likely to have comorbidities such as cardiovascular diseases, diabetes, and obesity, whereas influenza patients more commonly have pulmonary diseases and immunocompromised conditions . This difference in comorbidities can influence the severity and outcomes of the infections.
Conclusion
While COVID-19 and influenza share several clinical features, they also exhibit distinct differences in symptoms, laboratory findings, radiographic signs, and outcomes. COVID-19 tends to result in more severe complications and higher mortality rates compared to influenza. Understanding these differences is crucial for timely diagnosis and effective management of both diseases, especially during their concurrent circulation.
Sources and full results
Most relevant research papers on this topic